Arbovirus Infections
Recent clinical, regulatory, research and industry developments relating to this disease.
Recognition of Arboviruses by the Mosquito Immune System.
Critical review of the vector status of Aedes albopictus.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes8
- Arbovirus Infections3
- Aedes1
- Arboviruses1
- Culex1
- Culicidae1
- Flavivirus1
- Neglected Diseases1
- Vaccine-Preventable Diseases1
Leading journals3
- Medical and veterinary entomology2
- Scientific reports2
- Biomolecules1
Leading researchers8
- Bertola M1
- Bichaud L1
- Charrel RN1
- Di Luca M1
- Feliciangeli MD1
- Fortuna C1
- Gradoni F1
- Gradoni L1
Affiliations (unnormalised)6
- College of Agriculture1
- National University of Samoa1
- Oceania University of Medicine1
- Sapienza Università di Roma1
- School of Biodiversity1
- Tupua Tamasese Meaole Hospital1
Disease profile
A grounded synthesis of the condition — overview, causes, mechanism, risk factors and current standard of care.
Arbovirus infections are infections caused by arthropod-borne viruses, meaning viruses transmitted by vectors such as mosquitoes, ticks, sandflies, or biting midges. They are a broad and unspecified group of infections that can affect humans and animals worldwide. The literature notes that many infections are mild and flu-like, but severe disease and death can also occur.
The cause is infection with arthropod-borne viruses transmitted through the bites of infected vectors. The grounding specifically identifies mosquitoes, ticks, sandflies, and biting midges as transmission routes. No single viral cause is specified because the category is general and unspecified.
Arboviruses are maintained and transmitted through interactions between the virus and arthropod vectors, with mosquito immune responses influencing viral replication and transmission. The literature describes a coevolved balance between arboviruses and vector immunity, and disruption of this balance may alter transmission. The disease manifestations in humans range from mild flu-like illness to severe disease.
Exposure to arthropod vectors is the main risk factor, especially in settings where mosquitoes, ticks, sandflies, or biting midges are present. The literature also highlights vector spread and increased vector density as contributors to transmission, including expansion of Aedes albopictus into new regions and increases in breeding sites and blood sources for sandflies. Human migration, deforestation, urbanization, and interruption of vector control activities are also associated with spread in the supplied reviews.
The grounding does not provide a disease-specific treatment standard for arbovirus infections. It indicates that few vaccines are available and that control efforts focus on vector population control and interruption of virus transmission. At the modality level, this supports prevention and vector-control approaches rather than a specific drug-class treatment.
AI-generated summary grounded in MeSH and 3 peer-reviewed sources. Informational only — not medical advice. Generated 2026-07-07.
Reference
Authoritative identity, definition & identifiers.
Infections caused by arthropod-borne viruses, general or unspecified.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.